ALPINE IMMUNE SCIENCES, INC. Increase (Decrease) in Deferred Revenue
ALPINE IMMUNE SCIENCES, INC. reported Increase (Decrease) in Deferred Revenue of -$479.00 thousand for the 6-month period ending 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-08-09
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$240.00K.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$239.00K.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was -$128.00K.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was -$128.00K.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in deferred revenue for fiscal 2017 was -$1.73M.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in deferred revenue for fiscal 2016 was -$2.95M, a 159.50% decline from fiscal 2015.
- ALPINE IMMUNE SCIENCES, INC. increase (decrease) in deferred revenue for fiscal 2015 was $4.96M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|
| 2018-06-30 | -$240.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$479.00K 10-Q · filed 2018-08-09 | -$607.00K derived: sum of 3 quarters · filed 2018-08-09 | -$735.00K derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | -$239.00K 10-Q · filed 2018-05-14 | -$367.00K derived: sum of 2 quarters · filed 2018-05-14 | -$495.00K derived: sum of 3 quarters · filed 2018-05-14 | -$1.23M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-12-31 | -$128.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$256.00K derived: sum of 2 quarters · filed 2018-03-28 | -$994.00K derived: sum of 3 quarters · filed 2018-08-09 | -$1.73M 10-K · filed 2018-03-28 |
| 2017-09-30 | -$128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$866.00K derived: sum of 2 quarters · filed 2018-08-09 | -$1.60M 10-Q · filed 2017-11-14 | -$2.34M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-06-30 | -$738.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$1.48M 10-Q · filed 2018-08-09 | -$2.21M derived: sum of 3 quarters · filed 2018-08-09 | |
| 2017-03-31 | -$737.00K 10-Q · filed 2018-05-14 | -$1.48M derived: sum of 2 quarters · filed 2018-05-14 | ||
| 2016-12-31 | -$738.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | -$2.95M 10-K · filed 2018-03-28 | ||
| 2016-09-30 | -$2.21M 10-Q · filed 2017-11-14 | |||
| 2015-12-31 | $4.96M 10-K · filed 2018-03-28 |